Summary
Joshua Hunsberger, PhD is a strategic technology and ecosystem leader driving national-scale innovation in regenerative medicine and biomanufacturing. As CTO of the RegenMed Development Organization and Chief Partnership Officer for the NSF Piedmont Triad Regenerative Medicine Engine, he builds consortia, regulatory pathways, and AI-enabled platforms that accelerate translation from organoids and digital twins to clinical and commercial scale. He pairs deep bench research experience—from NIH and Yale neuroscience work to Wake Forest translational projects—with practical consortium-building that connects industry partners like Roche, Amgen, and Pfizer to test beds, patent pools, and workforce pipelines. Joshua’s career blends rigorous academic training with program design expertise, enabling him to de-risk technologies while unlocking funding and commercialization routes. An under-the-radar strength is his history of creating educational and community programs (FAES courses, industry symposiums, and podcasts) that broaden adoption and talent development across the field. Based in Winston-Salem, he focuses on ecosystem-scale solutions that translate scientific advances into economic and patient impact.
8 years of coding experience
7 years of employment as a software developer
BA Neuroscience, BA Neuroscience at Wesleyan University
PhD Neuroscience, PhD Neuroscience at Yale University